133 related articles for article (PubMed ID: 911602)
1. Acebutolol metabolite plasma concentration during chronic oral therapy.
Winkle RA; Meffin PJ; Ricks WB; Harrison DC
Br J Clin Pharmacol; 1977 Oct; 4(5):519-22. PubMed ID: 911602
[TBL] [Abstract][Full Text] [Related]
2. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
3. Effects of equipotent blocking doses of acebutolol, acebutolol's primary metabolite, and propranolol on left ventricular hemodynamics in conscious awake dogs.
Magder S; Rubenson D; Griffin G; Kernoff R; Harrison DC
J Cardiovasc Pharmacol; 1983; 5(4):691-6. PubMed ID: 6193369
[TBL] [Abstract][Full Text] [Related]
4. Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.
Meffin PF; Harapat SR; Harrison DC
Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):31-51. PubMed ID: 968178
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent acebutolol disposition after oral administration.
Meffin PJ; Winkle RA; Peters FA; Harrison DC
Clin Pharmacol Ther; 1978 Nov; 24(5):542-7. PubMed ID: 699478
[TBL] [Abstract][Full Text] [Related]
6. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
Munn S; Bailey RR; Begg E; Ebert R; Ferry DG
N Z Med J; 1980 Apr; 91(658):289-91. PubMed ID: 6930006
[TBL] [Abstract][Full Text] [Related]
7. Prevention of postischaemic ventricular fibrillation by long term beta adrenoceptor blockade with acebutolol in the anaesthetised dog.
Puddu PE; Jouve R; Langlet F; Guillen JC; Fornaris M; Torresani J; Reale A
Cardiovasc Res; 1986 Oct; 20(10):721-6. PubMed ID: 2431780
[TBL] [Abstract][Full Text] [Related]
8. Circulatory effects of intravenous and oral acebutolol in acute myocardial infarction.
Silke B; Nelson G; Verma SP; Clarke J; Baliga G; Taylor SH
Clin Pharmacol Ther; 1985 Sep; 38(3):266-72. PubMed ID: 4028620
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
Frick MH; Kala R
Am J Cardiol; 1981 Nov; 48(5):911-6. PubMed ID: 6118059
[TBL] [Abstract][Full Text] [Related]
10. Acebutolol and coronary artery surgery. Plasma levels following oral pre-operative treatment.
Thoms GM; Reece IJ; Odom NJ; Kaye CM; Sankey MG
Anaesthesia; 1982 Nov; 37(11):1078-83. PubMed ID: 6982635
[TBL] [Abstract][Full Text] [Related]
11. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of supraventricular arrhythmias with acebutolol.
Williams DO; Tatelbaum R; Most AS
Am J Cardiol; 1979 Sep; 44(3):521-5. PubMed ID: 382821
[TBL] [Abstract][Full Text] [Related]
13. Suppression of premature ventricular contractions by acebutolol.
Gradman AH; Winkle RA; Fitzgerald JW; Meffin PJ; Stoner J; Bell PA; Harrison DC
Circulation; 1977 May; 55(5):785-91. PubMed ID: 66105
[TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmic effects and blood level of acebutolol as for oral administration (author's transl)].
Suzuki M; Terukina M; Akamatsu T; Suzuki K
Kokyu To Junkan; 1977 Sep; 25(9):813-22. PubMed ID: 918406
[No Abstract] [Full Text] [Related]
15. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
[TBL] [Abstract][Full Text] [Related]
16. Acebutolol and oral surgery: plasma levels following a single oral dose.
Fergusson NV; Dalgleish JG; Saunders DA
Ann R Coll Surg Engl; 1985 Mar; 67(2):124-6. PubMed ID: 3883878
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of acebutolol.
Ryan JR
Am Heart J; 1985 May; 109(5 Pt 2):1131-6. PubMed ID: 2859776
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).
Gulaid AA; James IM; Kaye CM; Lewellen OR; Roberts E; Sankey M; Smith J; Templeton R; Thomas RJ
Biopharm Drug Dispos; 1981; 2(2):103-14. PubMed ID: 7248475
[TBL] [Abstract][Full Text] [Related]
19. Acebutolol for premature ventricular contractions: short- and long-term effects.
de Soyza N
Am Heart J; 1985 May; 109(5 Pt 2):1205-9. PubMed ID: 3993536
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
Abernethy DR; Arendt RM; Greenblatt DJ
Am Heart J; 1985 May; 109(5 Pt 2):1120-5. PubMed ID: 2859774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
